Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.76 USD 1.47% Market Closed
Market Cap: 815.2m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abcellera Biologics Inc
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Other Current Assets
$45.9m
CAGR 3-Years
97%
CAGR 5-Years
138%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Other Current Assets
CA$32.2k
CAGR 3-Years
69%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Replicel Life Sciences Inc
XTSX:RP
Other Current Assets
CA$60.4k
CAGR 3-Years
36%
CAGR 5-Years
-3%
CAGR 10-Years
-1%
Innovotech Inc
XTSX:IOT
Other Current Assets
CA$46.8k
CAGR 3-Years
26%
CAGR 5-Years
31%
CAGR 10-Years
9%
No Stocks Found

Abcellera Biologics Inc
Glance View

Market Cap
802.7m USD
Industry
Life Sciences Tools & Services

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. The company is headquartered in Vancouver, British Columbia and currently employs 386 full-time employees. The company went IPO on 2020-12-11. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.

ABCL Intrinsic Value
1.67 USD
Overvaluation 39%
Intrinsic Value
Price

See Also

What is Abcellera Biologics Inc's Other Current Assets?
Other Current Assets
45.9m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Other Current Assets amounts to 45.9m USD.

What is Abcellera Biologics Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
138%

Over the last year, the Other Current Assets growth was 35%. The average annual Other Current Assets growth rates for Abcellera Biologics Inc have been 97% over the past three years , 138% over the past five years .

Back to Top